The Wegovy Pill Is Now Available, but There's 1 Big Catch Patients Need to Know
The FDA-approved oral Wegovy pill offers easier access to weight loss treatment with similar effectiveness to injections, boosting Novo Nordisk shares by 15%, experts say.
6 Articles
6 Articles
Starting 2026 by shedding some pounds? Wegovy’s new weight-loss pill is rolling out in Florida
How to lose weight in 2026 with the new Wegovy pill. Also in this month's Your Health column: Is the super flu a real thing; and accessing mental health help in several languages.
Wegovy pill could increase access to obesity treatment, condition impacting 37.7% of Ky. adults
The U.S. Food and Drug Administration has approved the first pill version of a GLP-1 drug for weight loss, a move that could significantly widen access to the treatment for obesity.
First GLP-1 Pill for Weight Loss Launches in U.S.
Photo courtesy of Tom Little, Reuters. This week, Novo Nordisk launched the first oral glucagon-like peptide-1 (GLP-1) medication for weight management in the U.S., giving patients a new daily pill option alongside traditional injectable therapies. The tablet, branded as Wegovy, was approved by the U.S. Food and Drug Administration in December 2025. It is now available by prescription at more than 70,000 pharmacies nationwide and through telehea…
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium




